- Report
- August 2022
- 327 Pages
Global
From €3202EUR$3,600USD£2,817GBP
- Report
- August 2023
- 145 Pages
Global
From €3500EUR$4,216USD£3,187GBP
- Report
- July 2023
- 83 Pages
Global
From €3500EUR$4,216USD£3,187GBP
- Report
- June 2023
- 132 Pages
Global
From €845EUR$950USD£743GBP
- Report
- November 2021
- 545 Pages
Global
From €3557EUR$4,000USD£3,130GBP
- Report
- November 2021
- 1184 Pages
Global
From €5336EUR$6,000USD£4,694GBP
- Report
- November 2021
- 1165 Pages
Global
From €5336EUR$6,000USD£4,694GBP
- Report
- November 2021
- 233 Pages
Global
From €2223EUR$2,500USD£1,956GBP

RNA sequencing (RNA-Seq) is a powerful tool used in genomics to analyze the expression of genes. It is used to measure the amount of RNA present in a sample, which can be used to identify and quantify the expression of genes. RNA-Seq can also be used to detect genetic mutations, alternative splicing, and other structural variations. RNA-Seq is used in a variety of applications, including gene expression profiling, transcriptome analysis, and biomarker discovery.
The RNA sequencing market is growing rapidly, driven by the increasing demand for personalized medicine and the need for more accurate diagnosis and treatment of diseases. The market is also driven by the increasing availability of high-throughput sequencing technologies and the development of new sequencing platforms.
Some companies in the RNA sequencing market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10X Genomics. Show Less Read more